Prion-Like Brain Damage Possible Without Infection, Study Finds

ADN
Recent findings suggest that brain damage resembling that caused by prion diseases may develop even in the absence of infectious agents, raising new questions about the origins and mechanisms of neurodegenerative conditions.
TL;DR
- Chronic inflammation may drive neurodegeneration, not just prions.
- New study challenges origins of Alzheimer’s and similar diseases.
- Reducing inflammation could help prevent neurodegenerative diseases.
Rethinking the Origins of Neurodegenerative Diseases
A widely accepted view in neuroscience has long attributed disorders such as Creutzfeldt-Jakob disease and certain forms of dementia to one culprit: misfolded, infectious proteins called prions. Yet, recent work led by immunologist Burim Ametaj at the University of Alberta is compelling experts to reconsider. In a study on transgenic mice, his team demonstrated that classic brain changes—such as amyloid plaques and spongiform lesions—can arise even when infectious prions are absent.
The Central Role of Chronic Inflammation
What’s truly remarkable about these findings is the spotlight they place on persistent inflammation. Researchers designed six experimental groups, exposing mice to different combinations: a saline solution (serving as the control), a bacterial endotoxin known as LPS, a toxic yet non-infectious form of the PrP protein, or various mixes including authentic prions. The striking outcome? Even in the total absence of any infectious agent, it was enough for chronic inflammation (prompted by LPS) to occur alongside misfolded proteins for neurodegenerative symptoms akin to those in prion diseases to develop.
Toward New Avenues for Prevention and Treatment
This evidence doesn’t merely challenge established dogma—it opens new therapeutic horizons. As Ametaj himself observes, these findings “profoundly disrupt our understanding,” suggesting that the story isn’t solely about infectious proteins. Compellingly, bacterial endotoxins have been detected in the brains of individuals with Alzheimer’s disease. This raises an urgent question: could strategies targeting chronic inflammation lower the risk or delay onset?
Several factors explain this shift in focus:
- Diminish exposure to bacterial endotoxins
- Promote an anti-inflammatory lifestyle
- Monitor chronic inflammation from an early age
A Paradigm Shift—and New Hope?
If research continues to reveal that non-infectious protein precursors and inflammation play central roles in neurodegeneration, prevention may increasingly resemble approaches used against cardiovascular diseases: addressing modifiable risks early rather than intervening only after significant damage. While much remains to be confirmed, this evolving perspective could offer a renewed sense of hope for those affected by these devastating conditions—and perhaps inspire greater efforts toward prevention long before symptoms emerge.